EPO Patents = 1

Trademarks = 4

Forward Citations = 111

Loading Chart...

4 inventors (with patents filed for the assignee):

Lynn R Skow (2 out of 9 patents)

James Franklin Drake (2 out of 8 patents)

Jacques Borg (2 out of 2 patents)

4. Mark Harold Ereth (1 out of 2 patents)

5. James F Drake, Jr (5 patents)

6. Ann Gronda (0 patent)

4 patents: Sort by Forward Citations

1. 7517355 - Method of supporting and/or applying particulate materials (2009-04-14),

2. 6992233 - Material delivery system (2006-01-31),

3. 5447959 - Method of using derivatives of long chain fatty alcohols to treat (1995-09-05),

4. 5243094 - Derivatives of long chain fatty alcohols, their uses, particularly as (1993-09-07),

Company Overview

Medafor, Inc. is a leading medical technology company focused on developing and commercializing innovative hemostatic technologies. Their flagship product, Arista AH, is a plant-based, bio-absorbable hemostatic powder that rapidly stops bleeding and enhances wound healing. Medafor's mission is to improve patient outcomes and reduce healthcare costs through advanced hemostatic solutions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

4 Patents

#362 in Minneapolis, MN

#1,649 in Minnesota

#60,597 in US

Minneapolis, MN, United States of America

Medafor, Inc.

Forward Citations = 111

4 inventors:

Lynn R Skow (2 out of 9 patents)

James Franklin Drake (2 out of 8 patents)

Jacques Borg (2 out of 2 patents)

4. Mark Harold Ereth (1 out of 2 patents)

5. James F Drake, Jr (5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Medafor, Inc.. Retrieved from https://idiyas.com/company/medafor

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]